PCSK9 and Tyrosinemia type 1: As Pcsk9 is a target relevant to hypercholesterolaemia treatment and Hpd silencing can rescue the lethal phenotype of hereditary tyrosinemia type 1 in mice, we separately targeted eight sgRNA sites in Hpd and seven sgRNA sites in Pcsk9 with different deaminase CBEs.